Hangzhou Joinstar and Response Biomedical in $9 Million Deal

Hangzhou Joinstar Biomedical Technology, a China IVD company, and Response Biomedical of Canada will co-develop multiple assays to run on Joinstar's high throughput rapid immunoassay analyzer. Joinstar said its new analyzer has much higher throughput than the current crop of point-of-care machines. Response will be paid a total of $8.82 million for its work. More details.... Stock Symbols: (TSX: RBM; OTCBB: RPBIF) Share this with colleagues: // //